HomeinvestmentGSK plans $30 billion US investment as pharma tariff threat looms investment GSK plans $30 billion US investment as pharma tariff threat looms By web-interns@dakdan.com September 17, 2025 0 27 Share XLinkedinReddIt The company said its new facilities will Share XLinkedinReddIt Previous articleUK Looks to US to Adopt More Crypto-Friendly ApproachNext articleWith Trump in the U.K., GSK touts $30 billion investment in U.S. over 5 years web-interns@dakdan.com RELATED ARTICLES investment Paraguay offers direct permanent residency with $150,000 investment April 21, 2026 investment Google testimony challenges key claim in Indonesian corruption trial April 21, 2026 investment Polymarket in Talks to Raise $400M at $15B Valuation: Report April 21, 2026 - Advertisment - Most Popular Paraguay offers direct permanent residency with $150,000 investment April 21, 2026 Google testimony challenges key claim in Indonesian corruption trial April 21, 2026 Google testimony challenges key claim in Indonesian corruption trial April 21, 2026 Eli Lilly’s $3.25B acquisition of Kelonia Therapeutics caps startup’s tortuous ride April 21, 2026 Load more Recent Comments